Global Nerve Repair Biomaterials Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Global Nerve Repair Biomaterials Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

  • Healthcare
  • Upcoming Reports
  • Sep 2024
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Global Nerve Repair Biomaterials Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2024 –2031
Diagramm Marktgröße (Basisjahr)
USD 9.75 Billion
Diagramm Marktgröße (Prognosejahr)
USD 28.82 Billion
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Stryker
  • Collagen Matrix
  • Axogen Corporation.
  • Checkpoint Surgical
  • Polyganics

Global Nerve Repair Biomaterials Market Segmentation, By Products (Neurostimulation and Neuromodulation Devices), Application (Neurostimulation and Neuromodulation Applications, Direct Nerve Repair or Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Industry Trends and Forecast to 2031.

Nerve Repair Biomaterials Market

Nerve Repair Biomaterials Market Analysis

The nervous system made up of the brain, spinal cord, and peripheral nerves is susceptible to various types of injury due to the complex and delicate structures. The high incidence of nerve injuries is escalating the growth of nerve repair biomaterials market. These nerves are fragile and easily damaged, and hence can interfere with the brain's ability to communicate with muscles and organs.

Nerve Repair Biomaterials Market Size

Global nerve repair biomaterials market size was valued at USD 9.75 billion in 2023 and is projected to reach USD 28.82 billion by 2031, with a CAGR of 14.50% during the forecast period of 2024 to 2031.

Report Scope and Market Segmentation       

Attributes

Nerve Repair Biomaterials Key Market Insights

Segmentation

  • By Products: Neurostimulation and Neuromodulation Devices
  • By Application: Neurostimulation and Neuromodulation Applications, Direct Nerve Repair or Neurorrhaphy, Nerve Grafting, Stem Cell Therapy
  • By Sales Channel: Direct Sales, Distributors, and Online Sale

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

Stryker (US), Collagen Matrix, Inc. (US), Axogen Corporation. (US), Checkpoint Surgical, Inc. (US), Polyganics (Netherlands), Synovis Micro Companies Alliance, Inc. (US), Medtronic Plc. (US), Boston Scientific (US), Abbott (US), LivaNova PLC (UK), , Cyberonics, Inc. (US), Nuvectra. (US), OrthoMed, Inc. (US), AxoGen, Inc. (US), Baxter International, Inc. (US),  Integra LifeSciences (US), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), KeriMedical (Switzerland), and BioWave Corporation (US), NeuroSigma (US), among others

Nerve Repair Biomaterials Market Definition

The nerve repair and regeneration products consist of neuro-stimulation, neuromodulation devices, and biomaterials. These nerve repair biomaterials are used to operate trauma to neurodegenerative diseases, such as Parkinson's disease, multiple sclerosis, Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy, among others.

Nerve Repair Biomaterials Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers:

  • Incidence of Nerve Injuries

The increase in the number of nerve injuries is one of the major factors driving the growth of the nerve repair biomaterials market.

  • Geriatric Population

The rise in the geriatric population accelerate the market growth as elderly population is more prone to neurological and epidemic disorders.

  • Government Support

The surge in government support for neurologic disorder research in funds and investments further influences the market.

Opportunities

Furthermore, the research in neurology extends profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, potential of stem cell therapy in nerve repair and regeneration will further expand the market.

Restraints/Challenges

On the other hand, stringent regulatory requirements for product approvals and difficulties in treating large nerve gaps are expected to obstruct market growth. Also, preference for drug therapies over nerve repair and regeneration products and concerns regarding product recalls are projected to challenge the market of the nerve repair biomaterials in 2024-2031.

This nerve repair biomaterials market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on nerve repair biomaterials market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Nerve Repair Biomaterials Market Scope

The nerve repair biomaterials market is segmented on the basis of products and application. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

Application

  • Neurostimulation and Neuromodulation Applications
  • Direct Nerve Repair or Neurorrhaphy
  • Nerve Grafting
  • Stem Cell Therapy

Nerve Repair Biomaterials Market Regional Analysis

The nerve repair biomaterials market is analysed and market size insights and trends are provided by country, products and application as referenced above.

The countries covered in the nerve repair biomaterials market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nerve repair biomaterials market because of the well-developed healthcare industry and presence of leading medical diagnostics manufacturers within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increase in number of patients suffering from chronic diseases in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The nerve repair biomaterials market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nerve repair biomaterials market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nerve repair biomaterials market. The data is available for historic period 2010-2020.

Nerve Repair Biomaterials Market Share

The nerve repair biomaterials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nerve repair biomaterials market.

Nerve Repair Biomaterials Market Leaders Operating in the Market Are:

  • Stryker (US)
  • Collagen Matrix, Inc. (US)
  • Axogen Corporation. (US)
  • Checkpoint Surgical, Inc. (US)
  • Polyganics (Netherlands)
  • Synovis Micro Companies Alliance, Inc. (US)
  • Medtronic Plc. (US)
  • Boston Scientific (US)
  • Abbott (US)
  • LivaNova PLC (UK)
  • Cyberonics, Inc. (US)
  • Nuvectra. (US)
  • OrthoMed, Inc. (US)
  • AxoGen, Inc. (US)
  • Baxter International, Inc. (US)
  • Integra LifeSciences (US)
  • NeuroPace, Inc. (US)
  • Soterix Medical, Inc. (US)
  • Nevro Corp (US)
  • Synapse Biomedical, Inc. (US)
  • KeriMedical (Switzerland)
  • BioWave Corporation (US)
  • NeuroSigma (US)

Latest Developments in Nerve Repair Biomaterials Market

  • In January’2020, Medtronic received CE Mark for its InterStim Micro neurostimulator and InterStim SureScan™ MRI leads. The technologies are clear for commercial sale and clinical use in Europe and offer full-body MRI scan eligible and lifestyle-friendly choices.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The market is segmented based on Segmentation, By Products (Neurostimulation and Neuromodulation Devices), Application (Neurostimulation and Neuromodulation Applications, Direct Nerve Repair or Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Industry Trends and Forecast to 2031. .
The Global Nerve Repair Biomaterials Market size was valued at USD 9.75 USD Billion in 2023.
The Global Nerve Repair Biomaterials Market is projected to grow at a CAGR of 14.5% during the forecast period of 2024 to 2031.
The major players operating in the market include Stryker, Collagen Matrix , Axogen Corporation., Checkpoint Surgical , Polyganics, Synovis Micro Companies Alliance , Medtronic Plc., Boston Scientific, Abbott, LivaNova PLC, Cyberonics , Nuvectra., OrthoMed , AxoGen , Baxter International , Integra LifeSciences, NeuroPace , Soterix Medical , Nevro Corp, Synapse Biomedical , KeriMedical, BioWave Corporation, NeuroSigma.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.